GSK launches anti-shingles vaccine in India, Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com

Shingrix was approved by the US Food and Drug Administration (FDA) for the prevention of shingles in adults 50 years of age or older in 2017. In 2018, the European Commission gave Shingrix approval for the prevention of shingles in adults 50 years of age or older. Global data estimates suggest that 1 out of 3 people develops shingles in their lifetime., Shingrix was approved by the US Food and Drug Administration (FDA) for the prevention of shingles in adults 50 years of age or older in 2017. In 2018, the European Commission gave Shingrix approval for the prevention of shingles in adults 50 years of age or older. Global data estimates suggest that 1 out of 3 people develops shingles in their lifetime., , Read More

Leave a Reply

Your email address will not be published. Required fields are marked *